Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Jan;69(1):606–612. doi: 10.1128/jvi.69.1.606-612.1995

Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.

G Allen 1, M Yeargan 1, L R Costa 1, R Cross 1
PMCID: PMC188619  PMID: 7983765

Abstract

An experimental system that permits sensitive and reproducible detection of equine herpesvirus 1 (EHV-1)-specific cytotoxic T-lymphocyte (CTL) activity in the horse was developed. Peripheral blood mononuclear cells (PBMC) collected from immune horses were restimulated in vitro by culture with live EHV-1. Cytotoxic activity against virus-infected, pokeweed mitogen-stimulated lymphoblast targets was assessed in a 4-h 51Cr release assay. The optimal conditions for in vitro stimulation of equine memory CTLs and for preparation of EHV-1-infected target cells expressing viral antigens were systematically identified by individually testing the effects of variations in responder cell concentration, culture medium composition, serum type, incubation time, antigen form, and exogenous mediator content. By using this optimized system for generation and assay of equine CTLs, the development of EHV-1-specific cytotoxic responses in 12 horses was evaluated after experimental viral infection. CTLs with the capacity for killing EHV-1-infected target cells were detected in equine PBMC as early as 1 week postinfection, reached maximal levels by 2 to 3 weeks, and remained detectable for a year after infection. Equine effector cells mediating lysis of EHV-1-infected targets were predominantly CD8+ T lymphocytes, and the cytotoxicity was specific for virus and restricted by major histocompatibility complex class I molecules. The results define a reliable and convenient experimental system for generation and assay of EHV-1 CTLs which can now be used for more-detailed characterization of the equine CTL response to infection by this herpesvirus pathogen.

Full Text

The Full Text of this article is available as a PDF (262.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen G. P., Bryans J. T. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog Vet Microbiol Immunol. 1986;2:78–144. [PubMed] [Google Scholar]
  2. Allen G. P. The Equine Virology Research Foundation--a view from abroad. Equine Vet J. 1994 Jul;26(4):259–262. doi: 10.1111/j.2042-3306.1994.tb04385.x. [DOI] [PubMed] [Google Scholar]
  3. Antczak D. F., Bailey E., Barger B., Guerin G., Lazary S., McClure J., Mottironi V. D., Symons R., Templeton J., Varewyck H. Joint report of the Third International Workshop on Lymphocyte Alloantigens of the Horse, Kennett Square, Pennsylvania, 25-27 April 1984. Anim Genet. 1986;17(4):363–373. doi: 10.1111/j.1365-2052.1986.tb00730.x. [DOI] [PubMed] [Google Scholar]
  4. Bailey E. Identification and genetics of horse lymphocyte alloantigens. Immunogenetics. 1980;11(5):499–506. doi: 10.1007/BF01567818. [DOI] [PubMed] [Google Scholar]
  5. Bailey E. Population studies on the ELA system in American standardbred and thoroughbred mares. Anim Blood Groups Biochem Genet. 1983;14(3):201–211. doi: 10.1111/j.1365-2052.1983.tb01073.x. [DOI] [PubMed] [Google Scholar]
  6. Bryans J. T. On immunity to disease caused by equine herpesvirus 1. J Am Vet Med Assoc. 1969 Jul 15;155(2):294–300. [PubMed] [Google Scholar]
  7. Burrows R., Goodridge D., Denyer M. S. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus. Vet Rec. 1984 Apr 14;114(15):369–374. doi: 10.1136/vr.114.15.369. [DOI] [PubMed] [Google Scholar]
  8. Bürki F., Nowotny N., Oulehla J., Schmehlik O., Möstl K., Pallan C., Rossmanith E. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1. Zentralbl Veterinarmed B. 1991 Aug;38(6):432–440. doi: 10.1111/j.1439-0450.1991.tb00892.x. [DOI] [PubMed] [Google Scholar]
  9. Bürki F., Rossmanith W., Nowotny N., Pallan C., Möstl K., Lussy H. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet Q. 1990 Apr;12(2):80–86. doi: 10.1080/01652176.1990.9694249. [DOI] [PubMed] [Google Scholar]
  10. Campos M., Rossi C. R. In vitro induction of cytotoxic lymphocytes from infectious bovine rhinotracheitis virus hyperimmune cattle. Am J Vet Res. 1986 Nov;47(11):2411–2414. [PubMed] [Google Scholar]
  11. Chowdhury S. I., Kubin G., Ludwig H. Equine herpesvirus type 1 (EHV-1) induced abortions and paralysis in a Lipizzaner stud: a contribution to the classification of equine herpesviruses. Arch Virol. 1986;90(3-4):273–288. doi: 10.1007/BF01317376. [DOI] [PubMed] [Google Scholar]
  12. Crabb B. S., Allen G. P., Studdert M. J. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies. J Gen Virol. 1991 Sep;72(Pt 9):2075–2082. doi: 10.1099/0022-1317-72-9-2075. [DOI] [PubMed] [Google Scholar]
  13. Crowhurst F. A., Dickinson G., Burrows R. An outbreak of paresis in mares and geldings associated with equid herpesvirus 1. Vet Rec. 1981 Dec 12;109(24):527–528. [PubMed] [Google Scholar]
  14. DOLL E. R., CROWE M. E. W., BRYANS J. T., McCOLLUM W. H. Infection immunity in equine virus abortion. Cornell Vet. 1955 Jul;45(3):387–410. [PubMed] [Google Scholar]
  15. Dutta S. K., Campbell D. L. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares. Can J Comp Med. 1977 Oct;41(4):404–408. [PMC free article] [PubMed] [Google Scholar]
  16. Edington N., Bridges C. G., Patel J. R. Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Arch Virol. 1986;90(1-2):111–124. doi: 10.1007/BF01314149. [DOI] [PubMed] [Google Scholar]
  17. Edington N., Smyth B., Griffiths L. The role of endothelial cell infection in the endometrium, placenta and foetus of equid herpesvirus 1 (EHV-1) abortions. J Comp Pathol. 1991 May;104(4):379–387. doi: 10.1016/s0021-9975(08)80148-x. [DOI] [PubMed] [Google Scholar]
  18. Gibson J. S., O'Neill T., Thackray A., Hannant D., Field H. J. Serological responses of specific pathogen-free foals to equine herpesvirus-1: primary and secondary infection, and reactivation. Vet Microbiol. 1992 Oct;32(3-4):199–214. doi: 10.1016/0378-1135(92)90145-j. [DOI] [PubMed] [Google Scholar]
  19. Gibson J. S., Slater J. D., Awan A. R., Field H. J. Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Arch Virol. 1992;123(3-4):351–366. doi: 10.1007/BF01317269. [DOI] [PubMed] [Google Scholar]
  20. Greenwood R. E., Simson A. R. Clinical report of a paralytic syndrome affecting stallions, mares and foals on a thoroughbred studfarm. Equine Vet J. 1980 Jul;12(3):113–117. doi: 10.1111/j.2042-3306.1980.tb03397.x. [DOI] [PubMed] [Google Scholar]
  21. Jackson T., Kendrick J. W. Paralysis of horses associated with equine herpesvirus 1 infection. J Am Vet Med Assoc. 1971 Apr 15;158(8):1351–1357. [PubMed] [Google Scholar]
  22. Mumford J. A., Bates J. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus. Vet Rec. 1984 Apr 14;114(15):375–381. doi: 10.1136/vr.114.15.375. [DOI] [PubMed] [Google Scholar]
  23. Ostlund E. N. The equine herpesviruses. Vet Clin North Am Equine Pract. 1993 Aug;9(2):283–294. doi: 10.1016/s0749-0739(17)30396-6. [DOI] [PubMed] [Google Scholar]
  24. Scott J. C., Dutta S. K., Myrup A. C. In vivo harboring of equine herpesvirus-1 in leukocyte populations and subpopulations and their quantitation from experimentally infected ponies. Am J Vet Res. 1983 Jul;44(7):1344–1348. [PubMed] [Google Scholar]
  25. Smith K. C., Whitwell K. E., Mumford J. A., Gower S. M., Hannant D., Tearle J. P. An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1. Equine Vet J. 1993 Jan;25(1):36–40. doi: 10.1111/j.2042-3306.1993.tb02898.x. [DOI] [PubMed] [Google Scholar]
  26. Song W., Collisson E. W., Billingsley P. M., Brown W. C. Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats. J Virol. 1992 Sep;66(9):5409–5417. doi: 10.1128/jvi.66.9.5409-5417.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Splitter G. A., Eskra L., Abruzzini A. F. Cloned bovine cytolytic T cells recognize bovine herpes virus-1 in a genetically restricted, antigen-specific manner. Immunology. 1988 Jan;63(1):145–150. [PMC free article] [PubMed] [Google Scholar]
  28. Whitwell K. E., Blunden A. S. Pathological findings in horses dying during an outbreak of the paralytic form of Equid herpesvirus type 1 (EHV-1) infection. Equine Vet J. 1992 Jan;24(1):13–19. doi: 10.1111/j.2042-3306.1992.tb02771.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES